RHYTHM PHARMACEUTICALS, INC. (RYTM) ROI
- 2026-06-30: ROI -98.21%.
- 2026-03-31: ROI -87.60%.
- 2025-12-31: ROI -79.49%.
- 2025-09-30: ROI -74.61%.
Complete source-backed roi history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | -98.21% |
| 2026-03-31 | -87.60% |
| 2025-12-31 | -79.49% |
| 2025-09-30 | -74.61% |
| 2025-06-30 | -187.02% |
| 2025-03-31 | -131.31% |
| 2024-12-31 | -198.09% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | -79.49% |
| 2024-12-31 | -198.12% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |